News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
FDA asks mRNA vaccine makers to widen age range for rare heart risk warning
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback